IFRS 17

Also known as: Insurance Contracts

framework · accounting · regulatory-standard

IASB standard establishing recognition, measurement, and disclosure principles for insurance contracts, effective 2023.

IFRS 17 (Insurance Contracts) is the IASB standard establishing recognition, measurement, presentation, and disclosure principles for insurance contracts. Issued in May 2017 with an originally proposed 2021 effective date, it was deferred to annual periods beginning on or after 1 January 2023 in response to industry concerns about implementation feasibility. IFRS 17 replaced IFRS 4, an explicitly interim standard that permitted insurers to continue using national-GAAP measurement, producing extraordinary cross-jurisdictional inconsistency in insurance accounting. The new standard requires a current-fulfilment-value measurement approach: best-estimate cash flows, discounted using rates that reflect the characteristics of the cash flows, with explicit risk adjustment and a contractual service margin (CSM) representing the unearned profit at issuance recognized over the coverage period. Three measurement approaches exist: the General Measurement Model (GMM), the Premium Allocation Approach (PAA) for short-duration contracts, and the Variable Fee Approach (VFA) for direct participating contracts.

Originators

IASB Insurance Contracts project (initiated 1997 by IASC); IASB chair Hans Hoogervorst and successive technical leadership shepherded the standard through extensive exposure-draft and re-exposure stages 2007-2017 high

Year / Decade

1997 (IASC project initiation); 2017 (IFRS 17 issued); 2023 (effective) high

Primary sources

IASB (2017). IFRS 17, Insurance Contracts, IFRS Foundation (2017). Effects Analysis: IFRS 17 Insurance Contracts, IASB (2020). Amendments to IFRS 17 (deferral and targeted modifications) high

Core components

Primary use case

Recognition and measurement of insurance contracts issued by IFRS-reporting insurers in EU, UK, Canada, Australia, Japan, and other adopting jurisdictions; fundamental restatement of insurer financial statements for periods beginning 2023 onward; basis for cross-border insurance financial analysis; input to insurer ratings, M&A pricing, and capital allocation decisions; complement (not replacement) of regulatory solvency reporting.

Common criticisms

Lineage

Child of
IFRS
Siblings
Statutory Accounting Principles, IFRS 15, IFRS 16